EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Xpert MTB/RIF Ultra performance on bronchial specimens in diagnosing pulmonary tuberculosis in Vancouver, Canada

Cole Schonhofer, Jennifer Bilawka, Scott Apperley, Christopher F Lowe, Michael Payne, Nancy Matic, Victor Leung, Marc G Romney, Patrick Tang, Aleksandra Stefanovic

Journal of Medical Microbiology · 06.06.2025 · 74 (6)

DOI: 10.1099/jmm.0.002022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 06.06.2025. Verfasst von Cole Schonhofer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Mycobacterium tuberculosis, Molecular Diagnostic Techniques, Bronchi. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In cases where sputum is non-diagnostic or unavailable, bronchoscopy can yield high-value respiratory samples for tuberculosis (TB) diagnosis. Whilst Mycobacterium tuberculosis (MTB) complex culture remains the gold standard, molecular assays such as Xpert MTB/RIF Ultra (Xpert Ultra) are increasingly being used for rapid diagnosis. Gap Statement. Xpert Ultra is increasingly used for TB diagnosis and has been extensively evaluated on sputum specimens, but assessment of performance on bronchoscopy samples is more limited.

Aim

To retrospectively evaluate the performance of Xpert Ultra on bronchoscopy specimens in comparison to culture in a low-incidence, high-resource setting. Methodology. Patients with a clinical suspicion of TB, who had non-diagnostic sputum or limited sputum production and underwent bronchoscopy between March 2019 and October 2023, were included in the study. Bronchoscopy specimens comprised bronchoalveolar lavages, bronchial washings and endobronchial ultrasound lymph node tissue biopsies. All included specimens underwent acid-fast bacilli (AFB) smear, mycobacterial culture and Xpert Ultra. Positive MTB culture was considered the reference standard for TB diagnosis.

Results

One hundred thirty-five bronchoscopy samples from 126 patients were included. Cultures were positive for MTB in 47 out of 126 (37.3%) of included patients. Overall, positive percent agreement (PPA) and negative percent agreement (NPA) of Xpert Ultra to MTB culture were 93.6% and 98.7%, respectively. In 19 AFB smear-positive cases, Xpert Ultra had 100% PPA and NPA, whilst in 28 smear-negative cases, PPA and NPA were 89.3% and 98.6%, respectively. On average, positive culture results were available after 15.2 days of incubation (range, 5–42 days) versus 24 h for Xpert Ultra. Xpert Ultra PCR cycle threshold values correlated strongly with AFB-smear grade and time-to-culture positivity.

Conclusion

Xpert Ultra performed on specimens collected via bronchoscopy demonstrated excellent agreement with culture, even in smear-negative cases. Our results support the use of the Ultra on bronchoscopy specimens for accurate and rapid TB diagnosis in a low-incidence setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, PulmonaryMycobacterium tuberculosisMolecular Diagnostic TechniquesBronchiHumansMaleBronchoscopyFemaleRetrospective StudiesMiddle AgedAdultSputumAgedSensitivity and SpecificityBronchoalveolar Lavage FluidCanada

Stichwörter der Autor:innen

GeneXpert MTB/RIF UltraMycobacterium tuberculosisbronchoscopy

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Division of Medical Microbiology and Virology, St. Paul's Hospital, Providence Health Care, Vancouver, Canada.
  • Division of Respiratory Medicine, St. Paul's Hospital, Providence Health Care, Vancouver, Canada.

Zitieren

APA

Schonhofer, C., Bilawka, J., Apperley, S., Lowe, C. F., Payne, M., Matic, N., Leung, V., Romney, M. G., Tang, P., & Stefanovic, A. (2025). Xpert MTB/RIF Ultra performance on bronchial specimens in diagnosing pulmonary tuberculosis in Vancouver, Canada. Journal of Medical Microbiology, 74(6). https://doi.org/10.1099/jmm.0.002022

Vancouver

Schonhofer C, Bilawka J, Apperley S, Lowe CF, Payne M, Matic N, et al. Xpert MTB/RIF Ultra performance on bronchial specimens in diagnosing pulmonary tuberculosis in Vancouver, Canada. Journal of Medical Microbiology. 2025;74(6). doi:10.1099/jmm.0.002022

BibTeX
@article{Schonhofer2025,
  author = {Schonhofer, Cole and Bilawka, Jennifer and Apperley, Scott and Lowe, Christopher F and Payne, Michael and Matic, Nancy and Leung, Victor and Romney, Marc G and Tang, Patrick and Stefanovic, Aleksandra},
  title = {Xpert MTB/RIF Ultra performance on bronchial specimens in diagnosing pulmonary tuberculosis in Vancouver, Canada},
  journal = {Journal of Medical Microbiology},
  year = {2025},
  volume = {74},
  number = {6},
  doi = {10.1099/jmm.0.002022}
}
Kostenlos starten →